Freckles (Ephelides)
Freckles (ephelides) are among the most common benign epidermal pigment disorders. They appear as small macules, 1–3 mm across, ranging from light to dark brown, sharply defined but with irregular edges. They favor sun-exposed skin such as the center of the face (nose and cheeks), the nape, neck, shoulders and forearms.
Freckles pose no threat to general health and do not turn into skin cancer, but they can have a real impact on facial appearance and serve as a biomarker of skin that is highly sensitive to ultraviolet (UV) damage. They have a strong genetic basis, tied directly to variants of the melanocortin-1 receptor (MC1R) gene. Unlike other pigmented lesions, freckles change with the seasons: they darken and multiply in summer under UV exposure, then fade markedly or almost disappear in winter.
In everyday practice in Vietnam, however, freckles are easily confused with solar lentigines, Hori nevus (acquired bilateral nevus of Ota-like macules, ABNOM), melasma or post-inflammatory hyperpigmentation (PIH). Unproven home remedies such as dabbing on strong homemade acid (TCA), applying traditional herbal pastes, or overuse of deep-burning CO2 laser at unregulated beauty salons often lead to pitted scars, permanent white scars or severe post-inflammatory hyperpigmentation.
At Haute-Derma, we treat freckles by combining detailed skin imaging (VISIA and dermoscopy), ultrashort-pulse 532 nm/1064 nm picosecond laser, and a regimen that suppresses melanin production from within. This approach clears melanin from the epidermis while leaving healthy tissue intact, helping results last and preventing recurrence.
How Freckles Form: Pathogenesis and Cellular Mechanisms
Freckles arise from a complex interplay between genetic makeup (genotype) and an environmental trigger, ultraviolet (UV) light:
UV radiation (UVA/UVB) → keratinocytes release MSH and endothelin-1 → these bind to variant MC1R receptors on melanocytes → more pheomelanin is made and large melanosomes are transferred → melanin accumulates in epidermal keratinocytes → freckles form
- Melanocortin-1 Receptor Gene Polymorphism (MC1R): the MC1R gene encodes the receptor on pigment cells that binds melanocyte-stimulating hormone (MSH). In people with skin types I and II (fair skin, red or blond hair), or in carriers of MC1R variants (such as R151C, R160W and D294H), cAMP signaling is altered. Production of eumelanin, the brown-black pigment that absorbs UV and protects the skin, falls, and production shifts toward pheomelanin, a red-yellow pigment that is less stable and breaks down readily into reactive oxygen species (ROS) that damage DNA.
- More Active, Not More Numerous, Melanocytes: this is the key biological feature that separates freckles from lentigines and moles (nevi):
- Freckled skin contains the same number of melanocytes as the normal skin around it.
- However, the melanocytes in a freckle are larger, carry many more dendrites and contain large stage III and IV melanosomes. When stimulated by UV light, they produce melanin at a greatly increased rate.
- The Role of Ultraviolet Light (UV-Induced Pigmentation): when UVB and UVA reach the skin, keratinocytes release growth factors and cytokines such as α-MSH, ACTH, endothelin-1 and stem cell factor (SCF). These signals push tyrosinase in melanocytes to maximum activity, ramping up the packaging of melanosomes and their transfer to neighboring epidermal keratinocytes, which creates dark brown spots on the skin surface.
Differential Diagnosis of Common Facial Pigmented Lesions
| Freckles (Ephelides) | Solar Lentigines (Sun Spots / Age Spots) | Hori Nevus (ABNOM) |
|---|---|---|
| Superficial epidermis (keratinocytes and basal layer) | Epidermis (basal layer with elongated rete ridges) | Deep dermis (pigment cells in the papillary and reticular dermis) |
| Small 1–3 mm macules with irregular edges, light to dark brown | Flat 3–20 mm macules, sharply defined, uniform brown | Gray-brown or blue-gray spots, 1–5 mm, symmetrical on both cheeks |
| Marked seasonal change: darker in summer, faded or gone in winter | No seasonal change; darken with age and cumulative UV exposure | No seasonal change; influenced by hormones |
| Children (from age 2–6), often runs in families | Middle-aged and older adults (> 40 years) | Young to middle-aged women (20–40 years) |
| Uniform mottled, dotted pigment network (mottled/starburst pattern) | Curved ridge-like bands of pigment with fingerprint-like borders | Cloud-like blue-gray/gray-brown dermal pigment |
Examination, Dermoscopy and Medical Screening at Haute-Derma
To get the best results and make sure no precancerous lesion or deep dermal pigment is missed, Haute-Derma follows a 4-step medical assessment:
- Multidimensional Skin Analysis With VISIA Evolution
- Measures UV spots (pigment visible under ultraviolet light) and brown spots (visible surface pigment).
- Maps the density and extent of freckling so laser energy settings can be tailored to each patient.
- Detailed Dermoscopy
- Assesses the epidermal pigment pattern: freckles show evenly distributed dots of melanin in the stratum corneum and basal layer.
- Rules out malignancy: no asymmetric pigmented follicular openings and no rhomboidal structures (the dermoscopic clues to melanoma on the face), no structureless gray-black areas and no abnormal vessels.
- Wood's Lamp Examination: 365 nm UV light is shone on the skin in a darkened room. Freckles lie entirely in the epidermis, so they stand out with clearly increased contrast (noticeably darker and sharper). If the pigment fades or does not change, Hori nevus or dermal melasma should be considered.
- Fitzpatrick Skin Type and Clinical History: Skin type (usually Fitzpatrick II, III or IV in Vietnamese patients) is determined so that a safe energy density (fluence) can be chosen, avoiding post-inflammatory hyperpigmentation (PIH).
Multilayer Picosecond Laser Treatment and Relapse Prevention at Haute-Derma
Freckle treatment at Haute-Derma follows three principles: clear epidermal pigment with picosecond laser, restore the skin barrier, and suppress the skin's own melanin production.
Picosecond Laser Pigment Clearance (Pico-Photoacoustic Therapy)
- Advantages of Picosecond Over Nanosecond (Classic Q-Switched) Lasers: picosecond lasers emit extremely short pulses measured in trillionths of a second, so the photoacoustic (pressure-wave) effect far outweighs the photothermal (heat) effect. Melanin is shattered into dust-like microparticles that macrophages can quickly clear and remove through the lymphatic system.
- Wavelength Selection and Treatment Settings:
- 532 nm wavelength: the gold-standard wavelength, strongly absorbed by superficial epidermal melanin. It is used for light to dark brown freckles in the upper epidermis, with a 3–5 mm spot size and gentle energy (0.6–1.2 J/cm²), producing ultra-thin micro-crusts without bleeding or damage to the basement membrane.
- 1064 nm wavelength (PTP/Genesis mode): used on darker skin (Fitzpatrick IV) to lower the risk of PIH, clear background pigment and rejuvenate the superficial microcirculation.
- Number of Sessions: usually just 1–3 sessions, 3–4 weeks apart, clearing 90–95% of the pigment.
Post-Laser Soothing and Skin Barrier Recovery
- Immediately after laser, a soothing recovery mask is applied, followed by cryo-electroporation with 3% tranexamic acid and EGF (epidermal growth factor).
- This interrupts the inflammatory cascade, cools the skin immediately, reduces redness and kick-starts natural epidermal healing.
Maintenance and Melanin-Suppressing Home Care (Topical Homecare)
To keep MC1R-driven pigmentation in check and stop freckles returning with sun exposure, Haute-Derma prescribes an essential maintenance plan:
- Tyrosinase inhibitors: daily alpha-arbutin 2–5%, kojic acid, vitamin C derivatives (SAP/MAP) or azelaic acid 10–15%.
- Melanosome transfer blockers: niacinamide 4–5% helps stop melanin moving from melanocytes into keratinocytes.
- Faster keratinocyte turnover: newer-generation retinoids (adapalene or retinol 0.5–1%) speed up the shedding of pigmented cells.
Medical-Grade Broad-Spectrum Sun Protection (Photoprotection Protocol)
- Apply a broad-spectrum sunscreen rated PPD > 16 / PA++++ that protects against UVA1, UVA2, UVB and high-energy visible light (HEVL/blue light).
- Patients are advised to reapply sunscreen every 2–3 hours and to take an oral photoprotective supplement containing fern extract (Polypodium leucotomos) to neutralize the reactive oxygen species generated in MC1R-sensitive skin.
